Evidence map›Paper›PMID 18628354›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2008

Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus.

Sebastiaan Hammer, Rutger W van der Meer, Hildo J Lamb, Hans H de Boer, Jeroen J Bax, Albert de Roos, Johannes A Romijn, Johannes W A Smit

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01761318 (Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus), which is not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01761318 phase4completedstarted 2013, after this paper: background citation

Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus

Ran2013Enrolled50Registered outcomes48Posted comparisons0ConditionsCardiovascular Disease, Diabetes Mellitus Type 2, Diastolic Dysfunction, Fatty LiverArmsliraglutide, Liraglutide - Placebo
Open the trial in the graph
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 72 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Human cardiac metabolism.Cell metabolism · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Metabolomics: a search for biomarkers of visceral fat and liver fat content.Metabolomics : Official journal of the Metabolomic Society · 2019
    Article
  13. Article
  14. Review
  15. The Flexibility of Ectopic Lipids.International journal of molecular sciences · 2016
    Review
  16. Lipid Use and Misuse by the Heart.Circulation research · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sebastiaan HammerDepts. of Endocrinology & Metabolism and Radiology ,Leiden University Medical Center, 2300 RC Leiden, the Netherlands. S.Hammer@LUMC.nl
Rutger W van der Meer
Hildo J Lamb
Hans H de Boer
Jeroen J Bax
Albert de Roos
Johannes A Romijn
Johannes W A Smit
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Short-term caloric restriction increases plasma levels of nonesterified fatty acids (NEFAs) and is associated with increased myocardial triglyceride (TG) content and decreased myocardial function in healthy subjects. Whether this flexibility of myocardial TG stores and myocardial function is also present in patients with type 2 diabetes mellitus (T2DM) is yet unknown. Myocardial TG content and left ventricular (LV) ratio between the early (E) and atrial (A) diastolic filling phase (E/A) were determined using magnetic resonance (MR) spectroscopy and MR imaging, respectively, before and after a 3-day very low-calorie diet (VLCD) in 11 patients with T2DM. In addition, we studied patients after a 3-day VLCD combined with the antilipolytic drug acipimox. The VLCD induced myocardial TG accumulation [from 0.66 +/- 0.09% (mean +/- SE, baseline) to 0.98 +/- 0.16%, P = 0.028] and a decrease in E/A ratio [from 1.00 +/- 0.05 (baseline) to 0.90 +/- 0.06, P = 0.002]. This was associated with increased plasma NEFA levels (from 0.57 +/- 0.08 mmol/l at baseline to 0.92 +/- 0.12, P = 0.019). After the VLCD with acipimox, myocardial TG content, diastolic function, and plasma NEFA levels were similar to baseline values. In conclusion, in patients with T2DM, a VLCD increases myocardial TG content and is associated with a decrease in LV diastolic function. These effects were not observed when a VLCD was combined with acipimox, illustrating the physiological flexibility of myocardial TG stores and myocardial function in patients with T2DM.

Indexed as

Adipose TissueBlood GlucoseBlood PressureCaloric RestrictionCholesterolDiabetes Mellitus, Type 2DiastoleFatty Acids, NonesterifiedGlycated HemoglobinHeart RateHumansHypolipidemic AgentsLiverMagnetic Resonance ImagingMaleMiddle AgedacipimoxBlood GlucoseCholesterolFatty Acids, NonesterifiedGlycated HemoglobinHypolipidemic AgentsPyrazinesTriglycerides

Identifiers

PMID18628354
OpenAlexW2099830497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.